Global Blood Plasma Derivatives Market to Reach US$ 74.1 Billion by 2032, Propelled by Rising Prevalence of Infectious Diseases

March 09, 2023 | Healthcare

IMARC Group's latest report, titled “Blood Plasma Derivatives Market Report by Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others), Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand's Disease, and Others), End User (Hospitals, Clinics, and Others), and Region 2024-2032," finds that the global blood plasma derivatives market size reached US$ 45.8 Billion in 2023. Blood plasma derivatives are concentrated forms of specific proteins made from plasma collected through fractionation. They are commonly used to kill viruses that cause hepatitis B, hemophilia A, bleeding disorders, immunodeficiency, hepatitis C, hypogammaglobulinemia, hemophilia B, and human immunodeficiency virus (HIV), as they are rich in proteins, minerals, salts, hormones, vitamins, and protease inhibitors. Some commonly used blood plasma derivatives include factor VIII, immunoglobulin, albumin, hyperimmune globulin, factor IX, and fresh frozen. They help improve nutrition, control body temperature and blood clotting, maintain osmotic pressure, enhance respiration and excretion, and control acid-base balance. At present, blood plasma derivatives are commonly stored at diagnostic centers, hospitals, clinics, and blood transfusion centers across the globe. 

Global Blood Plasma Derivatives Market Trends:

The rising prevalence of infectious diseases and the expanding geriatric population represent the primary factors driving the market growth. Moreover, the surging adoption of blood plasma derivatives to treat coronavirus disease (COVID-19) patients by convalescent plasma treatment is positively influencing the market growth. Apart from this, numerous technological advancements in the fractionation process that help separate blood plasma components and protein concentrates for clinical use are propelling the market growth. Additionally, continual improvements in existing procedures and the development of novel preservation techniques to produce targeted therapeutic products are other major growth-inducing factors. Besides this, the escalating demand for blood plasma derivatives due to the rise in the prevalence of life-threatening diseases, such as immunodeficiency disorders and hemophilia, has catalyzed market growth. This can be attributed to the presence of immunoglobins in blood plasma that are essential for the development of immunity and for maintaining the osmotic pressure in blood vessels, which further slows the onset of hemophilia and immune deficiency disorders. Other factors, including the rising awareness regarding blood and plasma donation, favorable government initiatives to promote blood donation camps, and rapid growth in the healthcare industry, are also anticipated to create a positive market outlook. Looking forward, IMARC Group expects the market value to reach US$ 74.1 Billion by 2032, expanding at a CAGR of 5.4% during 2024-2032.

Market Summary:

  • On the basis of the type, the market has been divided into albumin, factor VIII, factor IX, immunoglobulin, hyperimmune globulin, and others. 
  • Based on the application, the market has been segmented into hemophilia, hypogammaglobulinemia, immunodeficiency diseases, Von Willebrand’s disease, and others. 
  • The market has been categorized based on the end user into hospitals, clinics, and others. 
  • Region-wise, the market has been segregated into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others) and Middle East and Africa.
  • The competitive landscape of the market has also been analyzed, with some of the key players being Baxter International Inc., Bayer AG, CSL Limited, Fusion Health Care Pvt. Ltd., Grifols S.A., Kedrion S.p.A., LFB S.A., Octapharma AG, Sanofi S.A., and Takeda Pharmaceutical Company Limited.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Type, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Baxter International Inc., Bayer AG, CSL Limited, Fusion Health Care Pvt. Ltd., Grifols S.A., Kedrion S.p.A., LFB S.A., Octapharma AG, Sanofi S.A. and Takeda Pharmaceutical Company Limited
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N A
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Blood Plasma Derivatives Market to Reach US$ 74.1 Billion by 2032, Propelled by Rising Prevalence of Infectious Diseases
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More